EUVIMEDEUVIMED entdecken
Crossref

Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment

Yunkun Li, Yahui Wu, Zaixiang Fang, Yuxin Zhang, Haitao Ding, Long Ren, Lu Zhang, Qiyong Gong, Zhongwei Gu, Kui Luo iD

Advanced Materials · 2024-01 · 36 (2)

DOI: 10.1002/adma.202307263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 23.11.2023. Verfasst von Yunkun Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huaxi MR Research Center (HMRRC), Metabolomics and Proteomics Technology Platform, Frontiers Science Center for Disease-Rela…. Hauptthemen laut MEDLINE: Nanomedicine, Neoplasms. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unsatisfied tumor accumulation of chemotherapeutic drugs and a complicated immunosuppressive microenvironment diminish the immune response rate and the therapeutic effect. Surface modification of these drugs with target ligands can promote their cellular internalization, but the modified drugs may be subjected to unexpected immune recognition and clearance. Herein, a phenylboronic acid (PBA) group‐shieldable dendritic nanomedicine that integrates an immunogenic cell death (ICD)‐inducing agent (epirubicin, Epi) and an indoleamine 2,3‐dioxgenase 1 (IDO1) inhibitor (NLG919) is reported for tumor chemo‐immunotherapy. This NLG919‐loaded Epi‐conjugated PEGylated dendrimers bridged with boronate bonds (NLG919@Epi‐DBP) maintains a stable nanostructure during circulation. Under a moderate acidic condition, the PBA group exposes to the sialic acid residue on the tumor cell membrane to enhance the internalization and penetration of NLG919@Epi‐DBP. At pH 5.0, NLG919@Epi‐DBP rapidly disassembles to release the incorporated Epi and NLG919. Epi triggers robust ICD of tumor cells that evokes strong immune response. In addition, inhibition of the IDO1 activity downregulates the metabolism of L‐tryptophan to kynurenine, leading to a reduction in the recruitment of immunosuppressive cells and modulation of the tumor immune microenvironment. Collectively, this promising strategy has been demonstrated to evoke robust immune response as well as remodel the immunosuppressive microenvironment for an enhanced chemo‐immunotherapeutic effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineNeoplasmsHumansEpirubicinTryptophanImmunotherapyTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

IDO inhibitionchemo-immunotherapydendritic drug delivery systemtumor immune microenvironment reeducation

Substanzen

EpirubicinTryptophan

Autor:innen und Institutionen

  • Department of Radiology, Huaxi MR Research Center (HMRRC), Metabolomics and Proteomics Technology Platform, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China…
  • Functional and Molecular Imaging Key Laboratory of Sichuan Province, and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, China.
  • Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen, 361021, China.

ORCID-Profile: Kui Luo

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • West China Hospital, Sichuan University
  • Post-Doctor Research Project
  • China Postdoctoral Science Foundation

Zitieren

APA

Li, Y., Wu, Y., Fang, Z., Zhang, Y., Ding, H., Ren, L., Zhang, L., Gong, Q., Gu, Z., & Luo, K. (2024). Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment. Advanced Materials, 36(2). https://doi.org/10.1002/adma.202307263

Vancouver

Li Y, Wu Y, Fang Z, Zhang Y, Ding H, Ren L, et al. Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment. Advanced Materials. 2024;36(2). doi:10.1002/adma.202307263

BibTeX
@article{Li2024,
  author = {Li, Yunkun and Wu, Yahui and Fang, Zaixiang and Zhang, Yuxin and Ding, Haitao and Ren, Long and Zhang, Lu and Gong, Qiyong and Gu, Zhongwei and Luo, Kui},
  title = {Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {2},
  doi = {10.1002/adma.202307263}
}
Kostenlos starten →